Trust Point Inc. cut its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 47.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 12,703 shares of the company's stock after selling 11,421 shares during the quarter. Trust Point Inc.'s holdings in Option Care Health were worth $295,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of OPCH. UMB Bank n.a. boosted its position in shares of Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock worth $26,000 after buying an additional 750 shares during the period. GAMMA Investing LLC raised its holdings in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after purchasing an additional 1,446 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after purchasing an additional 2,757 shares during the last quarter. Finally, Quarry LP grew its position in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after purchasing an additional 2,628 shares in the last quarter. 98.05% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on OPCH. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. JPMorgan Chase & Co. increased their price target on Option Care Health from $38.00 to $40.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Barrington Research increased their price objective on Option Care Health from $32.00 to $33.00 and gave the company an "outperform" rating in a report on Tuesday, January 14th. Finally, UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a "neutral" rating and a $26.00 target price on the stock. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, Option Care Health has an average rating of "Moderate Buy" and a consensus target price of $32.25.
Check Out Our Latest Stock Analysis on Option Care Health
Option Care Health Price Performance
OPCH stock traded up $0.37 during mid-day trading on Monday, hitting $31.35. The stock had a trading volume of 936,565 shares, compared to its average volume of 1,853,453. The firm has a fifty day simple moving average of $26.04 and a 200 day simple moving average of $27.87. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $5.34 billion, a P/E ratio of 26.34, a P/E/G ratio of 2.19 and a beta of 1.35.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
